<ѻý>Medicare's 'Most Favored Nation' Drug-Pricing Rule in Limboѻý> Rule affecting Part B drugs was to take effect Jan. 1 but was stopped by federal court orders Jan 07, 2021
<ѻý>PET Scans Reveal Vascular Inflammationѻý> In giant cell arteritis, imaging confirmed clinical response Jan 07, 2021
<ѻý>Who Flares When SLE Patients Stop Hydroxychloroquine?ѻý> Flares more likely among minorities, younger patients, and those taking steroids Jan 05, 2021
<ѻý>Ozanimod a Winner in Ulcerative Colitisѻý> S1P receptor modulator effective for both induction and maintenance Dec 10, 2020
<ѻý>Colchicine Approval Took a Huge Toll on CMSѻý> As centuries-old drug is explored for COVID-19, study details the price of approval Nov 30, 2020
<ѻý>TYK2 Inhibition Promising in Psoriatic Arthritisѻý> Phase II study found significant benefits for two doses of novel agent Nov 10, 2020
<ѻý>More Evidence Early Mortality Persists in IBDѻý> Canadian study shows treatment advances haven't erased lifespan deficit Nov 09, 2020
<ѻý>COVID Complications Common with Rheumatic Diseaseѻý> Adverse outcomes included acute kidney injury and congestive heart failure Nov 08, 2020
<ѻý>Rinvoq for RA: Benefits Persist Beyond 1 Yearѻý> Manufacturer's extension study shows no loss of clinical response Nov 06, 2020
<ѻý>Nonsteroidal Topical, Nanodrug Active in Psoriasisѻý> Selected presentations from the European Academy of Dermatology and Venereology meeting Nov 04, 2020
<ѻý>Upadacitinib, Abatacept Go Head to Head in RAѻý> And the winner is... both, depending on whether efficacy or safety is the main criterion Oct 14, 2020
<ѻý>Depression and Biologic Use in Arthritis: Chicken or Egg?ѻý> Relationship appears to be bi-directional, researchers say Oct 02, 2020
<ѻý>Novel Biologic Promising in Mid-Stage Scleroderma Trialѻý> Significant differences seen at week 24 for the agent versus placebo on background therapy Sep 28, 2020
<ѻý>COVID-19 Storms: Bradykinin In, Cytokine Out?ѻý> Papers poke holes in cytokine storm as gene expression study offers a new theory Sep 11, 2020
<ѻý>Mepolizumab Offers Relief for Chronic Sinus Troubleѻý> Anti-IL5 biologic cut polyp size, need for surgery in chronic rhinosinusitis with nasal polyps Sep 10, 2020
<ѻý>Capsaicin Injection Improves Knee OA Painѻý> Investigational treatment targets capsaicin receptor to inactivate local pain fibers Sep 06, 2020
<ѻý>Novel Form of Muscle Relaxant Shows Benefitѻý> Tolperisone may help pain from acute back spasms without causing drowsiness Sep 05, 2020
<ѻý>Joint Effusion Protective in Hand OAѻý> Unlike synovitis, which was linked with both pain and progression Sep 03, 2020
<ѻý>Al Roker's Shoulder Replacementѻý> "Today" co-host and weatherman battles osteoarthritis pain Aug 25, 2020
<ѻý>Lupus Anticoagulant Tied to COVID Thrombosisѻý> Small study suggests consideration of therapeutic anticoagulation Aug 12, 2020
<ѻý>Few Risks for Sjogren's Patients With Joint Surgeryѻý> Transfusion rates raised but no increase for infection, revision, or mortality Jul 30, 2020
<ѻý>Tocilizumab Raises GI Risks in Rheumatoid Arthritisѻý> Double the risk of one rare but potentially deadly event compared with use of TNF inhibitors, large Swedish study found Jul 22, 2020
<ѻý>Targeting IL-23 Relieves Multiple Symptoms in PsAѻý> Both enthesitis and dactylitis improved with guselkumab treatment in psoriatic arthritis Jul 21, 2020
<ѻý>Colchicine Shows Promise in COVID-19 Patients, With Caveatsѻý> Clinical effects need further investigation, authors urge Jun 24, 2020
<ѻý>Muscle Relaxer Rx Doubled Over 12-Year Spanѻý> Spike in prescriptions among older adults particularly concerning, researchers note Jun 24, 2020
<ѻý>Gout: Methotrexate May Enhance Pegloticase Responseѻý> In small study, uric acid levels were reduced to near undetectable levels in almost 80% of patients Jun 09, 2020
<ѻý>Psoriatic Arthritis: Outcomes Similar for Cosentyx and Humiraѻý> Primary endpoint of superiority for secukinumab over adalimumab not met in a phase IIIb trial Jun 08, 2020
<ѻý>Voclosporin Beats Standard of Care in Lupus Nephritisѻý> High rates of response seen even among difficult-to-treat Hispanic patients Jun 05, 2020
<ѻý>Avacopan Superior to Steroids in ANCA Vasculitisѻý> Greater rates of remission and improved renal function seen with oral C5a receptor antagonist Jun 04, 2020
<ѻý>Another IL-6 Blocker Succeeds in Rheumatoid Arthritisѻý> Effective in patients with moderately to severely active disease in a phase III trial Jun 03, 2020
<ѻý>EULAR 2020: What to Expectѻý> Cancelled due to pandemic but extensive menu of virtual learning planned Jun 02, 2020
<ѻý>High-Dose Vitamin D Disappoints for Preventing Crohn’s Recurrenceѻý> No benefit seen despite substantial increase in serum 25-OH-D May 27, 2020
<ѻý>Biologics Don't Increase Melanoma Risk... Probablyѻý> Meta-analysis offers some reassurance, but leaves room for doubt May 20, 2020
<ѻý>Asthma, Inhaled Steroids, and COVID-19ѻý> The Skeptical Cardiologist weighs the links May 16, 2020
<ѻý>IL-17A Blockers Succeed in Spine Diseaseѻý> Secukinumab and ixekizumab best placebo for ankylosing spondylitis May 13, 2020
<ѻý>Study Backs Cytokine Targeting for COVID-19 Txѻý> Interrupting host inflammatory response shows promise May 08, 2020
<ѻý>CellCept Succeeds in ANCA Vasculitisѻý> Benefits, however, for only one serotype of antineutrophil cytoplasmic antibodies, study found May 07, 2020
<ѻý>Do You Believe in HCQ for COVID-19? It Will Break Your Heartѻý> Milton Packer believes advocacy of the drug is practicing politics, not medicine May 06, 2020
<ѻý>Rheumatoid Arthritis: Biologic Dose Cuts Feasibleѻý> Majority of patients who achieved remission, low disease activity could lower biologic intake without flaring Apr 30, 2020